KURA ONCOLOGY INC (KURA) Stock Income Statement
USA - NASDAQ:KURA - US50127T1097 - Common Stock
9.36 USD
+0.26 (+2.86%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 83.28M | 53.88M | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 302.98M | 247.08M | 165.80M | 139.87M | 131.26M | |||
| Research and Development | 212.73M | 169.97M | 115.23M | 92.81M | 84.72M | |||
| Selling, General, and Administrative Expenses | 90.25M | 77.11M | 50.57M | 47.05M | 46.54M | |||
| Operating Income | -219.71M | -193.19M | -165.80M | -139.87M | -131.26M | |||
| Interest Income/Expense | 24.78M | 21.13M | 13.07M | 3.93M | 990.00K | |||
| Other Income/Expense | N/A | 100.00K | 100.00K | 100.00K | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | -200.00K | |||
| Income Before Taxes | -194.93M | -171.97M | -152.63M | -135.84M | -130.47M | |||
| Income Tax | N/A | 2.02M | N/A | N/A | N/A | |||
| Net Income | -197.17M | -173.98M | -152.63M | -135.84M | -130.47M | |||
| EBITDA | -218.83M | -192.35M | -164.96M | -139.11M | -130.70M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.26 | -2.02 | -2.08 | -2.03 | -1.97 | |||
| Non GAAP EPS | -2.26 | -2.03 | -2.08 | -2.03 | -1.96 | |||
| Statistics | ||||||||
| Profit Margin | -236.76% | -322.89% | N/A | N/A | N/A | |||
| Operating Profit Margin | -263.82% | -358.55% | N/A | N/A | N/A | |||
All data in USD